Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 批发和零售业
Company Introduction 国药集团药业股份有限公司是一家主要经营药品生产、药品分销、药品物流业务的公司,属于医药产业的投资管理型企业.公司的主要产品是批发中成药、化学药制剂、化学原料药、抗生素、生化药品.本公司已经获得了有关药品批发、零售等药品经营的有关资格证书;国瑞药业有限公司已经获得了药品生产的有关资格证书,部分生产线的GMP认证证书;本公司生产的果糖二磷酸钠无菌冻干原料及其制剂(艾欣利尔)获得国家二类新药证书;公司是国家授权进行药品零售跨省连锁和药品网上销售的试点企业。
Main Business 以药品及器械配送为主，创新服务和电商为辅。
Legal Representative 姜修昌
Top Executives
董事长：姜修昌
董事：蒋昕,田国涛,李晓娟,刘勇,文德镛
独立董事：余兴喜,刘燊,陈明宇,史录文
Top 5 Shareholder
Shareholder name Nature Holding Date
国药控股股份有限公司限售股+流通A股54.72%30/09/2024
新华人寿保险股份有限公司－传统－普通保险产品－018L－CT001沪流通A股2.26%30/09/2024
香港中央结算有限公司流通A股2.09%30/09/2024
北京康辰药业股份有限公司流通A股1.36%30/09/2024
中国工商银行股份有限公司－中欧医疗健康混合型证券投资基金流通A股1.27%30/09/2024
Company Secretary 罗丽春
Solicitors 国浩律师（上海）事务所
Auditors 岳华会计师事务所有限责任公司
Tel No 010-67271828
Fax No 010-67271828
Website www.cncm.com.cn
Email gygfzqb@sinopharm.com
Company Address
Register: 北京市东城区永定门西滨河路8号院7楼西塔6-9层
Office: 北京市东城区永定门西滨河路8号院7楼西塔6-9层
Listing Date 27/11/2002
Shares Capital
Shares Capital: 754,502,998
Total A Share: 754,502,998
Listed A Share: 553,346,424
Non-tradable A Share: 201,156,574
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 2.844
DPS(RMB)* ¥ 0.854
NBV Per Share(RMB)* ¥ 20.909
Market Capitalization(RMB) 19.367B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.